Friday, November 30, 2018

US Court of Appeals Denies Actavis's Petition for Rehearing Regarding Validity of the Zubsolv® Patent

UPPSALA, Sweden, Nov. 30, 2018 /PRNewswire/ -- Orexo AB (publ.) today announces that the US Court of Appeals for the Federal Circuit has denied Actavis Elizabeth LLC's (Actavis) combined petition for panel rehearing and rehearing en banc in the case regarding Orexo's Zubsolv US patent...



from PR Newswire: https://ift.tt/2rcrSF1

No comments:

Post a Comment